Clinical and biomarker results of neoadjuvant phase II study of pembrolizumab and carboplatin plus docetaxel in triple-negative breast cancer (TNBC) (NeoPACT).
暂无分享，去创建一个
A. Godwin | R. Salgado | R. Madan | J. O’Shaughnessy | Q. Khan | P. Sharma | J. Wagner | Rachel Yoder | A. O’Dea | M. Phadnis | Christa R. Balanoff | J. M. Staley | Lauren Nye | S. Stecklein | Manana Elia | G. Crane | Deepti Satelli | Kelsey Schwensen | Priyanka Sharma | K. Larson | M. O'neil | A. O'Dea | J. Staley | Lauren E Nye